Company: VERA
Filing Date: 2025-04-03
Form Type: DEFA14A
Source: 0001140361-25-012036
Chunk: 0

Company: Vera Therapeutics, Inc.
Filing Date: 2025-04-03
Form: DEFA14A
Chunk 0
---
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.)

| Filed by the Registrant                    | ​ | ​ | ☒ |
| Filed by a party other than the Registrant | ​ | ​ | ☐ |

Check the appropriate box:

| ☐ | Preliminary Proxy Statement                                                     |
| ☐ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
| ☐ | Definitive Proxy Statement                                                      |
| ☒ | Definitive Additional Materials                                                 |
| ☐ | Soliciting Material Pursuant to § 240.14a-12                                    |

| Vera Therapeutics, Inc.                                                 |
| (Name of Registrant as Specified in Its Charter)                        |
| N/A                                                                     |
| (Name of Person(s) Filing Proxy Statement if other than the Registrant) |

Payment of Filing Fee (Check the appropriate box):

| ☒ | No fee required                                                                                     |
| ☐ | Fee paid previously with preliminary materials                                                      |
| ☐ | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11 |